Parkinson's Disease in Long-Term Care Residents Grant

Parkinson's Disease in Long-Term Care Residents Grant

Funder: The Foundation for Post-Acute and Long-Term Care Medicine (philanthropically supported by Acadia Pharmaceuticals)

Contact: Victoria Hann, Foundation Director, VHann@paltmed.org | 410-992-3134 | foundation@paltmed.org

Geographic Scope: United States (Maryland-based funder)

Purpose

The intent of this grant is to generate new information and formulate improved management strategies for residents of post-acute and long-term care facilities, specifically focused on Parkinson's Disease (PD). The grant aims to advance quality of life and care for residents with Parkinson's Disease through research addressing:
• Impact of PD on activities of daily living and quality of life
• Management of Parkinson's disease psychosis (PDP)
• Age-friendly and deprescribing care models
• Facility-based strategies improving outcomes for residents with PD

Broader questions of interest may also include:

Funding Information

• Award Amount: Up to $40,000 (combined direct and indirect costs, with indirect limited to 7% of total)
• Funding Source: Acadia Pharmaceuticals provided funding to the Foundation for PALTC to support this grant
• Project Duration: Must be feasible to accomplish in 12 months
• Funding Timeline: Letter of Inquiry deadline April 13, 2026; Full proposals due July 13, 2026; Award notification estimated September 1, 2026
• Funding Decision: Grant Committee of the Foundation for PALTC will evaluate submissions and make funding decisions independent of Acadia Pharmaceuticals

Eligibility Requirements

• Conducted in long-term care setting
• Feasible to accomplish in 12 months
• Demonstrates collaboration with facility staff
• Awardee is not a recipient of another Foundation for PALTC grant award
• Must have Investigational Review Board (IRB) approval or waiver before funding is provided as outlined in Code of Federal Regulations (45CFR46)

Evaluation Criteria for Letters of Inquiry

• Project need is clearly stated
• Project is strategically important to PALTmed and PALTC
• Objectives are specifically stated and measurable
• Methods (activities) are feasible within budget
• Applicant(s) has a high likelihood of success

Evaluation Criteria for Full Research Proposals

• Significance: Does the work align with Foundation's vision of fulfilling unmet educational, training, and scientific innovation?
• Investigator Capabilities: Evidence of success in previous research activities, grant awards, and publication history; letters of support from collaborators
• Innovation: Does proposal reflect innovative thinking and solutions to identified unmet needs?
• Soundness of Approach: Sufficient evidence of sound methodology, knowledge of field, clear and measurable objectives, realistic and achievable goals
• Environment: Organizational capacity to fulfill project requirements and support investigators
• Budget: Clear definition of resources/equipment/tools; if salary support requested, clear delineation of roles; if partial funding of larger project, other funds secured

Focus Areas

Projects specifically focused on Parkinson's Disease in long-term care settings, including:
• Activities of daily living outcomes for PD residents
• Psychosis management in residents with PD
• Age-friendly and deprescribing approaches
• Facility-based interventions to improve outcomes

What They Fund

• Investigator-initiated research projects addressing Parkinson's Disease in PALTC settings
• Projects aligned with PALTmed vision and mission

What They Don't Fund

• Projects by applicants who are recipients of another Foundation for PALTC grant award (concurrently)
• Projects without IRB approval or waiver
• Projects not conducted in long-term care settings
• Projects not feasible within 12 months